Prescient Therapeutics LimitedASX: PTX

Appendix 4E and 2023 Annual Report

· Issued by Prescient Therapeutics Limited

Filed with ASX · · 55 pages · English

Summary by 6ix AI

The report highlights a substantial increase in revenues from ordinary activities, while also noting a rise in losses attributable to the owners of the company. Additionally, the report emphasizes the company's strengthened financial position, supported by recent capital raises, which positions it well for future growth.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Prescient Therapeutics Limited on 6ix

Story so far

Earlier from Prescient Therapeutics

Later from Prescient Therapeutics

All Prescient Therapeutics news releases